A short well-folded TM protein, possibly with GPI anchor. Structurally weakly similar to PBN1, a GPI anchor biogenesis protein.. Localization: ER (by homology)
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | yes | yes: 8, no: 0 |
| NetGPI | no | yes: 0, no: 8 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 8 |
| GO:0110165 | cellular anatomical entity | 1 | 8 |
| GO:0005789 | endoplasmic reticulum membrane | 4 | 3 |
| GO:0031090 | organelle membrane | 3 | 3 |
Related structures:
AlphaFold database: A4H4S3
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0006497 | protein lipidation | 5 | 3 |
| GO:0006505 | GPI anchor metabolic process | 6 | 3 |
| GO:0006506 | GPI anchor biosynthetic process | 6 | 3 |
| GO:0006629 | lipid metabolic process | 3 | 3 |
| GO:0006643 | membrane lipid metabolic process | 4 | 3 |
| GO:0006644 | phospholipid metabolic process | 4 | 3 |
| GO:0006650 | glycerophospholipid metabolic process | 5 | 3 |
| GO:0006661 | phosphatidylinositol biosynthetic process | 6 | 3 |
| GO:0006664 | glycolipid metabolic process | 5 | 3 |
| GO:0006793 | phosphorus metabolic process | 3 | 3 |
| GO:0006796 | phosphate-containing compound metabolic process | 4 | 3 |
| GO:0006807 | nitrogen compound metabolic process | 2 | 3 |
| GO:0008152 | metabolic process | 1 | 3 |
| GO:0008610 | lipid biosynthetic process | 4 | 3 |
| GO:0008654 | phospholipid biosynthetic process | 5 | 3 |
| GO:0009058 | biosynthetic process | 2 | 3 |
| GO:0009247 | glycolipid biosynthetic process | 5 | 3 |
| GO:0009987 | cellular process | 1 | 3 |
| GO:0019538 | protein metabolic process | 3 | 3 |
| GO:0019637 | organophosphate metabolic process | 3 | 3 |
| GO:0036211 | protein modification process | 4 | 3 |
| GO:0043170 | macromolecule metabolic process | 3 | 3 |
| GO:0043412 | macromolecule modification | 4 | 3 |
| GO:0044237 | cellular metabolic process | 2 | 3 |
| GO:0044238 | primary metabolic process | 2 | 3 |
| GO:0044249 | cellular biosynthetic process | 3 | 3 |
| GO:0044255 | cellular lipid metabolic process | 3 | 3 |
| GO:0045017 | glycerolipid biosynthetic process | 4 | 3 |
| GO:0046467 | membrane lipid biosynthetic process | 4 | 3 |
| GO:0046474 | glycerophospholipid biosynthetic process | 5 | 3 |
| GO:0046486 | glycerolipid metabolic process | 4 | 3 |
| GO:0046488 | phosphatidylinositol metabolic process | 6 | 3 |
| GO:0071704 | organic substance metabolic process | 2 | 3 |
| GO:0090407 | organophosphate biosynthetic process | 4 | 3 |
| GO:1901135 | carbohydrate derivative metabolic process | 3 | 3 |
| GO:1901137 | carbohydrate derivative biosynthetic process | 4 | 3 |
| GO:1901564 | organonitrogen compound metabolic process | 3 | 3 |
| GO:1901576 | organic substance biosynthetic process | 3 | 3 |
| GO:1903509 | liposaccharide metabolic process | 4 | 3 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 200 | 202 | PF00675 | 0.545 |
| CLV_PCSK_KEX2_1 | 200 | 202 | PF00082 | 0.545 |
| CLV_PCSK_SKI1_1 | 48 | 52 | PF00082 | 0.406 |
| CLV_PCSK_SKI1_1 | 68 | 72 | PF00082 | 0.489 |
| DEG_APCC_DBOX_1 | 199 | 207 | PF00400 | 0.352 |
| DOC_CYCLIN_yCln2_LP_2 | 240 | 246 | PF00134 | 0.398 |
| DOC_CYCLIN_yCln2_LP_2 | 51 | 57 | PF00134 | 0.320 |
| DOC_MAPK_gen_1 | 166 | 173 | PF00069 | 0.303 |
| DOC_MAPK_gen_1 | 200 | 208 | PF00069 | 0.334 |
| DOC_MAPK_HePTP_8 | 230 | 242 | PF00069 | 0.250 |
| DOC_MAPK_MEF2A_6 | 166 | 173 | PF00069 | 0.262 |
| DOC_MAPK_MEF2A_6 | 233 | 242 | PF00069 | 0.349 |
| DOC_PP1_RVXF_1 | 7 | 14 | PF00149 | 0.393 |
| DOC_PP2B_LxvP_1 | 169 | 172 | PF13499 | 0.255 |
| DOC_PP2B_LxvP_1 | 240 | 243 | PF13499 | 0.387 |
| DOC_PP4_FxxP_1 | 64 | 67 | PF00568 | 0.315 |
| DOC_USP7_MATH_1 | 172 | 176 | PF00917 | 0.370 |
| DOC_USP7_MATH_1 | 214 | 218 | PF00917 | 0.495 |
| DOC_USP7_MATH_1 | 23 | 27 | PF00917 | 0.439 |
| DOC_WW_Pin1_4 | 105 | 110 | PF00397 | 0.302 |
| DOC_WW_Pin1_4 | 181 | 186 | PF00397 | 0.327 |
| DOC_WW_Pin1_4 | 234 | 239 | PF00397 | 0.399 |
| DOC_WW_Pin1_4 | 31 | 36 | PF00397 | 0.371 |
| DOC_WW_Pin1_4 | 86 | 91 | PF00397 | 0.429 |
| LIG_14-3-3_CanoR_1 | 215 | 221 | PF00244 | 0.425 |
| LIG_14-3-3_CanoR_1 | 61 | 65 | PF00244 | 0.357 |
| LIG_Actin_WH2_2 | 96 | 113 | PF00022 | 0.370 |
| LIG_BRCT_BRCA1_1 | 27 | 31 | PF00533 | 0.349 |
| LIG_BRCT_BRCA1_1 | 36 | 40 | PF00533 | 0.248 |
| LIG_Clathr_ClatBox_1 | 117 | 121 | PF01394 | 0.261 |
| LIG_eIF4E_1 | 252 | 258 | PF01652 | 0.398 |
| LIG_FHA_1 | 235 | 241 | PF00498 | 0.324 |
| LIG_FHA_1 | 5 | 11 | PF00498 | 0.445 |
| LIG_FHA_2 | 227 | 233 | PF00498 | 0.335 |
| LIG_LIR_Apic_2 | 52 | 56 | PF02991 | 0.340 |
| LIG_LIR_Apic_2 | 63 | 67 | PF02991 | 0.272 |
| LIG_LIR_Gen_1 | 175 | 185 | PF02991 | 0.409 |
| LIG_LIR_Gen_1 | 37 | 45 | PF02991 | 0.341 |
| LIG_LIR_Nem_3 | 104 | 110 | PF02991 | 0.284 |
| LIG_LIR_Nem_3 | 175 | 180 | PF02991 | 0.388 |
| LIG_LIR_Nem_3 | 183 | 189 | PF02991 | 0.437 |
| LIG_LIR_Nem_3 | 37 | 41 | PF02991 | 0.347 |
| LIG_NRBOX | 256 | 262 | PF00104 | 0.398 |
| LIG_SH2_CRK | 107 | 111 | PF00017 | 0.283 |
| LIG_SH2_CRK | 254 | 258 | PF00017 | 0.307 |
| LIG_SH2_CRK | 38 | 42 | PF00017 | 0.354 |
| LIG_SH2_SRC | 252 | 255 | PF00017 | 0.398 |
| LIG_SH2_STAP1 | 221 | 225 | PF00017 | 0.381 |
| LIG_SH2_STAT5 | 107 | 110 | PF00017 | 0.232 |
| LIG_SH2_STAT5 | 116 | 119 | PF00017 | 0.280 |
| LIG_SH2_STAT5 | 129 | 132 | PF00017 | 0.422 |
| LIG_SH2_STAT5 | 153 | 156 | PF00017 | 0.432 |
| LIG_SH2_STAT5 | 198 | 201 | PF00017 | 0.390 |
| LIG_SH2_STAT5 | 236 | 239 | PF00017 | 0.225 |
| LIG_SH2_STAT5 | 252 | 255 | PF00017 | 0.264 |
| LIG_SH2_STAT5 | 38 | 41 | PF00017 | 0.342 |
| LIG_SUMO_SIM_par_1 | 265 | 271 | PF11976 | 0.233 |
| LIG_TRAF2_1 | 229 | 232 | PF00917 | 0.339 |
| LIG_WW_1 | 35 | 38 | PF00397 | 0.353 |
| MOD_CDK_SPxK_1 | 105 | 111 | PF00069 | 0.361 |
| MOD_CK1_1 | 105 | 111 | PF00069 | 0.408 |
| MOD_CK1_1 | 217 | 223 | PF00069 | 0.431 |
| MOD_CK1_1 | 34 | 40 | PF00069 | 0.364 |
| MOD_CK1_1 | 89 | 95 | PF00069 | 0.345 |
| MOD_CK2_1 | 125 | 131 | PF00069 | 0.329 |
| MOD_CK2_1 | 226 | 232 | PF00069 | 0.339 |
| MOD_GlcNHglycan | 104 | 107 | PF01048 | 0.469 |
| MOD_GlcNHglycan | 147 | 150 | PF01048 | 0.599 |
| MOD_GlcNHglycan | 208 | 211 | PF01048 | 0.565 |
| MOD_GlcNHglycan | 223 | 226 | PF01048 | 0.566 |
| MOD_GlcNHglycan | 25 | 28 | PF01048 | 0.631 |
| MOD_GlcNHglycan | 254 | 257 | PF01048 | 0.233 |
| MOD_GlcNHglycan | 86 | 89 | PF01048 | 0.600 |
| MOD_GSK3_1 | 101 | 108 | PF00069 | 0.336 |
| MOD_GSK3_1 | 145 | 152 | PF00069 | 0.353 |
| MOD_GSK3_1 | 180 | 187 | PF00069 | 0.323 |
| MOD_GSK3_1 | 19 | 26 | PF00069 | 0.501 |
| MOD_GSK3_1 | 215 | 222 | PF00069 | 0.403 |
| MOD_GSK3_1 | 30 | 37 | PF00069 | 0.365 |
| MOD_NEK2_1 | 110 | 115 | PF00069 | 0.330 |
| MOD_NEK2_1 | 125 | 130 | PF00069 | 0.394 |
| MOD_NEK2_1 | 180 | 185 | PF00069 | 0.369 |
| MOD_NEK2_1 | 4 | 9 | PF00069 | 0.596 |
| MOD_NEK2_2 | 161 | 166 | PF00069 | 0.258 |
| MOD_PIKK_1 | 111 | 117 | PF00454 | 0.351 |
| MOD_PIKK_1 | 89 | 95 | PF00454 | 0.365 |
| MOD_PKA_2 | 214 | 220 | PF00069 | 0.443 |
| MOD_PKA_2 | 60 | 66 | PF00069 | 0.352 |
| MOD_Plk_1 | 134 | 140 | PF00069 | 0.285 |
| MOD_Plk_4 | 149 | 155 | PF00069 | 0.376 |
| MOD_Plk_4 | 36 | 42 | PF00069 | 0.358 |
| MOD_Plk_4 | 66 | 72 | PF00069 | 0.289 |
| MOD_ProDKin_1 | 105 | 111 | PF00069 | 0.306 |
| MOD_ProDKin_1 | 181 | 187 | PF00069 | 0.323 |
| MOD_ProDKin_1 | 234 | 240 | PF00069 | 0.396 |
| MOD_ProDKin_1 | 31 | 37 | PF00069 | 0.367 |
| MOD_ProDKin_1 | 86 | 92 | PF00069 | 0.428 |
| TRG_DiLeu_BaLyEn_6 | 6 | 11 | PF01217 | 0.396 |
| TRG_ENDOCYTIC_2 | 107 | 110 | PF00928 | 0.276 |
| TRG_ENDOCYTIC_2 | 177 | 180 | PF00928 | 0.338 |
| TRG_ENDOCYTIC_2 | 254 | 257 | PF00928 | 0.283 |
| TRG_ENDOCYTIC_2 | 38 | 41 | PF00928 | 0.342 |
| TRG_ER_diArg_1 | 165 | 168 | PF00400 | 0.421 |
| TRG_ER_diArg_1 | 199 | 201 | PF00400 | 0.360 |
| TRG_Pf-PMV_PEXEL_1 | 201 | 205 | PF00026 | 0.451 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1I4M9 | Leptomonas seymouri | 58% | 98% |
| A0A1X0NHE9 | Trypanosomatidae | 36% | 98% |
| A0A422NM30 | Trypanosoma rangeli | 38% | 100% |
| A4HT04 | Leishmania infantum | 77% | 100% |
| C9ZTN6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 38% | 92% |
| E9AKZ1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 77% | 100% |
| Q4QIW4 | Leishmania major | 77% | 100% |